DNA methylation profiles of long- and short-term glioblastoma survivors

Dietmar Krex, Thoraia Shinawi, Victoria Hill, Gabriele Schackert, Dean Gentle, Wenbin Wei, Eamonn R. Maher & Farida Latif
Objective: Median survival of patients with glioblastoma (GBM), the most common and malignant type of primary brain tumor, is 12 to 14 months. However, a small percentage of patients show long-term survival of 36 months or longer after diagnosis. Epigenetic profiles can provide molecular markers for[for full text, please go to the a.m. URL]